GLUT1 was significantly up-regulated in tumor samples (Additional file 7: Fig. S7A and B) and high levels of it was associated with a shorter survival in liver cancer patients (Additional file 7: Fig. S7C). Here, SLC2A1 is linked to liver cancer.